SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-001368
Filing Date
2022-02-18
Accepted
2022-02-17 17:46:19
Documents
157
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K irwd-20211231x10k.htm   iXBRL 10-K 3645744
2 EX-23.1 irwd-20211231xex23d1.htm EX-23.1 11744
3 EX-31.1 irwd-20211231xex31d1.htm EX-31.1 13054
4 EX-31.2 irwd-20211231xex31d2.htm EX-31.2 13008
5 EX-32.1 irwd-20211231xex32d1.htm EX-32.1 7486
6 EX-32.2 irwd-20211231xex32d2.htm EX-32.2 7435
7 GRAPHIC irwd-20211231x10k002.jpg GRAPHIC 29503
  Complete submission text file 0001558370-22-001368.txt   17351767

Data Files

Seq Description Document Type Size
8 EX-101.SCH irwd-20211231.xsd EX-101.SCH 124378
9 EX-101.CAL irwd-20211231_cal.xml EX-101.CAL 116082
10 EX-101.DEF irwd-20211231_def.xml EX-101.DEF 574442
11 EX-101.LAB irwd-20211231_lab.xml EX-101.LAB 950508
12 EX-101.PRE irwd-20211231_pre.xml EX-101.PRE 966324
151 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20211231x10k_htm.xml XML 3386918
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34620 | Film No.: 22649754
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences